A Firsthand Perspective of Pharma’s Failures with DE&I
PM360
MARCH 24, 2023
We covered the first one by looking at Organizational Structures , today, let’s dive into the second which is the toughest, not just for pharma, but for the entire country: Diversity, Equity, and Inclusion (DE&I). When we look at DE&I in pharma, how well we are doing depends on who you ask.
Let's personalize your content